Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Freed

Showing results (131-140 of 181) with videos related to

Pageof 19
Sort By:
AJR. American Journal of Roentgenology|November 18, 2004
Changes in magnetization transfer MRI correlate with spreading depression-induced astroglial reactivity and increased protein expression in miceChristopher D Lascola, Allen W Song, Timothy A Haystead, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 12, 2016
Pulse Afatinib for ERBB2 Exon 20 Insertion-Mutated Lung AdenocarcinomasDaniel B Costa, Susan E Jorge, Jason P Moran, et al.
International Journal of Hygiene and Environmental Health|May 11, 2005
Exposure pathway evaluations for sites that processed asbestos-contaminated vermiculiteBarbara A Anderson, Steve M Dearwent, James T Durant, et al.
American Journal of Human Genetics|April 23, 2003
A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4Lisa A Freed, James S Acierno, Daisy Dai, et al.
The American Journal of Cardiology|June 1, 1997
Relation of ultra-low frequency heart rate variability to the clinical course of chronic aortic regurgitationL A Freed, K M Stein, J S Borer, et al.
Journal of the American College of Cardiology|October 18, 2002
Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart StudyLisa A Freed, Emelia J Benjamin, Daniel Levy, et al.
The New England Journal of Medicine|July 1, 1999
Prevalence and clinical outcome of mitral-valve prolapseL A Freed, D Levy, R A Levine, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2016
Responses to the multitargeted MET/ALK/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutationSusan E Jorge, Sol Schulman, Jason A Freed, et al.
Cell Reports|June 15, 2017
Quantitative Analysis of the DNA Methylation Sensitivity of Transcription Factor ComplexesJudith F Kribelbauer, Oleg Laptenko, Siying Chen, et al.
The American Journal of Cardiology|April 6, 1999
Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)J P Singh, J C Evans, D Levy, et al.
Pageof 19

Showing results (131-140 of 181) with videos related to

Sort By:
Pageof 19
AJR. American Journal of Roentgenology|November 18, 2004
Changes in magnetization transfer MRI correlate with spreading depression-induced astroglial reactivity and increased protein expression in miceChristopher D Lascola, Allen W Song, Timothy A Haystead, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 12, 2016
Pulse Afatinib for ERBB2 Exon 20 Insertion-Mutated Lung AdenocarcinomasDaniel B Costa, Susan E Jorge, Jason P Moran, et al.
International Journal of Hygiene and Environmental Health|May 11, 2005
Exposure pathway evaluations for sites that processed asbestos-contaminated vermiculiteBarbara A Anderson, Steve M Dearwent, James T Durant, et al.
American Journal of Human Genetics|April 23, 2003
A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4Lisa A Freed, James S Acierno, Daisy Dai, et al.
The American Journal of Cardiology|June 1, 1997
Relation of ultra-low frequency heart rate variability to the clinical course of chronic aortic regurgitationL A Freed, K M Stein, J S Borer, et al.
Journal of the American College of Cardiology|October 18, 2002
Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart StudyLisa A Freed, Emelia J Benjamin, Daniel Levy, et al.
The New England Journal of Medicine|July 1, 1999
Prevalence and clinical outcome of mitral-valve prolapseL A Freed, D Levy, R A Levine, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2016
Responses to the multitargeted MET/ALK/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutationSusan E Jorge, Sol Schulman, Jason A Freed, et al.
Cell Reports|June 15, 2017
Quantitative Analysis of the DNA Methylation Sensitivity of Transcription Factor ComplexesJudith F Kribelbauer, Oleg Laptenko, Siying Chen, et al.
The American Journal of Cardiology|April 6, 1999
Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)J P Singh, J C Evans, D Levy, et al.
Pageof 19